Pharmaceutical Lead Generation and Sales Growth for Manufacturers
Pharmaceutical lead generation is a trust problem: buyers choose suppliers on credibility, documentation and relationships, and they take their time. Ink & Scale builds the sales and marketing system that finds qualified B2B buyers, answers their due-diligence questions before the first call, and keeps the conversation moving through a long sales cycle.
We work with pharmaceutical manufacturers on sales strategy, lead generation, digital marketing and automation. Our work covers how you sell, not what your products claim.
A no-cost, 30-minute conversation with the founder. No sales pitch.
Who we work with in pharma
This page is for owners, managing directors and sales or commercial directors at pharmaceutical manufacturers who sell to businesses: distributors, importers, institutional buyers, contract partners and other manufacturers.
Typical starting points:
- Orders depend on a few distributors or long-standing relationships.
- You want to enter or grow in new export markets and do not know who to reach.
- Enquiries come in but few turn into qualified conversations.
- Your website does not give technical and quality buyers what they need to shortlist you.
Why pharma B2B sales take longer and need more proof
A pharmaceutical purchase is a quality, regulatory and relationship decision, so several people review you before anyone talks price.
- Several reviewers. Procurement, quality, regulatory and commercial teams each look at different things.
- Documentation first. Buyers expect certifications, compliance history and technical documents early, and a gap here ends the conversation quietly.
- Long cycles. Samples, audits, registrations and approvals stretch the timeline, so follow-up has to continue for months without feeling like pressure.
- Market-by-market requirements. What a buyer needs in one country is not always what a buyer in another asks for, so each market needs its own approach.
- Tenders and partners. Some sales run through tenders or distributor and partner networks, where being easy to find and easy to shortlist matters.
The sales and marketing system we build for pharmaceutical manufacturers
We build one connected system, from deciding which buyers to pursue to following up through a long cycle.
- Market and buyer map. Which regions, buyer types and partners to pursue first, and in what order.
- A buyer-ready proof library. Your certifications, capability documents, quality information and references organized so a buyer's due-diligence questions are answered before they ask.
- Outbound and LinkedIn outreach to the procurement, business development and commercial roles that decide, with messaging that leads with credibility instead of discounts.
- Search visibility for the way buyers look for suppliers, through SEO and a website built for technical readers.
- Distributor and partner programs. A clear route for distributors and partners to find you, qualify you and work with you.
- Follow-up automation for long cycles. CRM and reminder workflows so no sample request, audit enquiry or quote goes cold (see Automation Development).
- Pipeline reporting that separates enquiries from qualified opportunities.
Selling pharma across five regions
We plan region by region, because buyers in each market ask for different proof and prefer different routes to supplier.
- North America and the UK: buyers typically expect clear quality documentation and a professional, easy-to-verify web presence before they respond.
- UAE and wider Middle East: relationships and local partners often carry weight, so introductions, distributors and in-person trust-building matter alongside digital reach.
- Africa: procurement routes vary widely by country, so we start by mapping which countries and channels fit your product range.
- India: a large domestic market with its own distributor and institutional channels, plus a base for export business.
Our work follows the marketing and advertising rules of each country, which vary; we do not advise on product claims or regulatory filings.
How an engagement typically starts
We start with a Strategy Call and a Growth & Revenue Audit, then build the plan with you.
- Strategy Call (30 minutes, with the founder): your markets, buyers and goals.
- Growth & Revenue Audit: pipeline, lead sources, website and sales process reviewed, with a written diagnosis and prioritized 90-day roadmap.
- Build and run: the proof library, outreach, website and follow-up system, with reporting on qualified conversations.
How engagements are priced: How we price.
Experience behind the work
- Founder background: more than six years in B2B business development across pharma, healthcare, personal care and specialty chemicals, with international accounts in eight countries since 2022. More about the founder.
- Related client work: Medeal Medical Supplies, a B2B medical-supplies distributor, where our ongoing engagement began with a commercial audit and a route-to-market plan (see Results).
Guides
- How Pharmaceutical Manufacturers Find Importers and DistributorsPharmaceutical manufacturers find importers and distributors by choosing target markets with evidence, making their credibility easy to verify, reaching the right roles with relevant outreach, and tracking each conversation through a long cycle. It is a process, not a mailing list.
- What a Buyer-Ready Document Pack Contains for Pharma B2B SalesA buyer-ready document pack is the set of verified documents a pharmaceutical buyer asks for before agreeing to a conversation: who you are, how you make and control your products, what you hold and can supply, and how to reach the right person. Having it ready shortens due diligence and signals that you are a serious supplier.
- How to Follow Up Through a Long Pharma Sales CycleIn a long pharma sales cycle you follow up by tracking every opportunity by stage, agreeing a dated next step at every contact, and making each touch useful, such as a new document or a relevant update, instead of asking "any news?". The goal is to stay present and helpful for months without creating pressure.
- LinkedIn Outreach to Pharma Procurement Teams: A Practical ApproachTo reach pharma procurement teams on LinkedIn, first make your own profile credible to a cautious buyer, then map everyone involved in the decision, not only procurement. Send short, specific first messages that offer something useful, and follow up patiently over weeks. Pharma buyers reply to suppliers who look prepared and respect their process.
Frequently asked questions
By being easy to find, easy to verify and easy to follow up. That means reaching the right buyers in each market, having documentation ready, and tracking every enquiry through a long cycle.
No. We work on how you find and win customers. We do not write or advise on therapeutic, medical or efficacy claims, and marketing rules vary by country.
We work with pharmaceutical manufacturers and with the distributors and wholesalers who sell their products. See Distribution and wholesale.
North America, the UK, the UAE, Africa and India.
Pharma sales cycles are long. Early signs are usually better-qualified conversations and a cleaner pipeline; orders follow the buyer's own timeline. We do not promise outcomes.
We scope and price after a Strategy Call, because cost depends on markets, channels and how much of your team we work with. See How we price.
Your main markets, how most orders reach you today and the one problem you most want solved.
Talk to us about your pharma pipeline
A no-cost, 30-minute conversation with the founder. No sales pitch.